Australia's ImpediMed gains on five-year $15 million growth capital facility
06/02/2025 01:00
** Shares of ImpediMed IPD.AX rise 5% to A$0.0525
** Stock set for best session since December 9, 2024, if
gains hold
** The medical technology co's unit executes an agreement
for a five-year $15 million growth capital facility with SWK
Funding
** Co adds that funds raised will be used to support growth
and commercialisation activities
** Stock down 3.9% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))